Implantica submits FDA PMA application Clinical Module 2 for RefluxStopâ„¢ for U.S. market approval ...

Implantica's lead product, RefluxStop™, is a CE-marked implant for the prevention of gastroesophageal reflux that will potentially create a paradigm shift in anti-reflux treatment as supported by ...

The global gastroesophageal reflux disease (GERD) device market is positioned for substantial growth over the next decade, ...

Some other lung-related conditions known to cause chest discomfort include: Pneumonia: This infection inflames the air sacs ...

Lucid Diagnostics Inc.  ("Lucid" or the "Company") a commercial-stage, cancer prevention medical diagnostics company, and subsidiary of PAVmed Inc. (Nasdaq: ...

Crohn’s disease is often associated ... This can view your esophagus and stomach, determining areas of inflammation, ...

Different foods and beverages can trigger acid reflux for different people. Examples of common dietary triggers for acid ...

Esophageal Catheters Market. The global esophageal catheters market is poised for significant expansion, with a projected market value of USD 2.2 billion in 2022, and a robust com ...

Proton pump inhibitors (PPIs) are widely used medications to manage common digestive issues like heartburn, acid reflux, and ...

Most stomach polyps are asymptomatic, meaning people do not know they have them until they have an endoscopy. Learn what is ...

Phathom is in the final stages of obtaining FDA feedback on the Phase 2 study and program investigating VOQUEZNA as a potential treatment for Eosinophilic Esophagitis (EoE) in adults and adolescents, ...